SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories informs about inspection of Company’s manufacturing facility

14 Jun 2023 Evaluate

Ipca Laboratories has informed that the US FDA conducted the inspection of the Company’s APIs manufacturing facility situated at Ratlam, Madhya Pradesh from 5th June, 2023 to 13th June, 2023. At the conclusion of the inspection, the US FDA issued a Form 483 with 11 observations. The Company will submit its comprehensive response on these observations to the US FDA within the stipulated time and shall work closely with the agency to resolve these issues at the earliest. The Company takes the quality and compliance issues with utmost importance and remains committed to maintain the highest standards of quality and compliance across all its manufacturing facilities.

The above information is a part of company’s filings submitted to BSE.




Ipca Laboratories Share Price

1553.00 9.05 (0.59%)
06-May-2026 09:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1829.35
Dr. Reddys Lab 1282.35
Cipla 1337.25
Zydus Lifesciences 918.75
Lupin 2380.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×